Skip to main content
Equibles
SKVI logo

SKVI · Skinvisible, Inc. · Metrics

Track SKVI — free

Use SKVI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SKVI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.18 +0.00 (+0.00%) At close · Nov 10
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors, among others, raises substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 13, 2026
Market Cap
$972,692
Shares
5.40M
Volume · Nov 10 798 Avg daily vol (15 sessions) 1085

SKVI metrics

59 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.18
Market cap
$972,692

Price action

23 metrics
Price change (1W)
+15.2%
Price change (30D)
+15.4%
Price change (3M)
+0.0%
Price change (6M)
-6.1%
Price change (YTD)
-21.9%
Price change (1Y)
-62.2%
Trailing year
Price change (5Y)
+9.0%
52-week high
$0.53
52-week low
$0.16
Change from 52-week high
-65.9%
Change from 52-week low
+15.4%
Annualized volatility
513.8%
Annualized volatility (3M)
—
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
—
RSI (14D)
46.8
Price vs SMA 50
-26.8%
Price vs SMA 200
-51.4%
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—

Company

3 metrics
Sector
Consumer Defensive
Industry
Household & Personal Products
Shares outstanding
5.40M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
341.6×
reciprocal yield 0.3%
EV / EBITDA
—
EV / EBIT
—
P / sales
48.6×
reciprocal yield 2.1%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
253.4
reciprocal yield 0.4%
Earnings yield
-106.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
362.1×
reciprocal yield 0.3%
EV / revenue historical average (5Y)
362.1×
reciprocal yield 0.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
100.0%
Operating margin
-2,294.9%
Trailing 12 months
Net margin
-5,156.6%
Gross profit (TTM)
$20,000
Operating profit (TTM)
−$458,981
Net income (TTM)
−$1.03M
Trailing 12 months
Diluted EPS (TTM)
$-0.11
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.00
Gross profit per diluted share (TTM)
$0.00
Operating profit per diluted share (TTM)
$-0.12
EBITDA per diluted share (TTM)
$-0.11
Net income per diluted share (TTM)
$-0.26
Operating cash flow per diluted share (TTM)
$-0.01
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-1.90

Growth

11 metrics
Revenue growth YoY
+0.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$20,000
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.0%
Year over year
Revenue CAGR (3Y)
-58.5%
Revenue CAGR (5Y)
-33.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-836.2%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
−$438,742
Free cash flow (TTM)
—
Quick ratio
0.0
Interest coverage
-0.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$5.86M
Latest balance sheet
Cash & equivalents
$3,959
Total assets
$123,334
Total debt
$5.86M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$3,838
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
$458,742
Stock compensation (TTM)
$223,090
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1085277 CUSIP 830703203 Visit website Investor relations